Showing results (11-20 of 80) with videos related to
Sort By:
Pageof 8
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 11, 2014
Expression of MAGE-A3/6 in primary breast cancer is associated with hormone receptor negative status, high histologic grade, and poor survivalMaha Ayyoub, Clara-Maria Scarlata, Ahmed Hamaï, et al.Cancer Immunology Research|April 30, 2014
CD4+ T effectors specific for the tumor antigen NY-ESO-1 are highly enriched at ovarian cancer sites and coexist with, but are distinct from, tumor-associated TregMaha Ayyoub, Pascale Pignon, Jean-Marc Classe, et al.European Journal of Immunology|January 31, 2003
Dissecting TCR-MHC/peptide complex interactions with A2/peptide multimers incorporating tumor antigen peptide variants: crucial role of interaction kinetics on functional outcomesValérie Dutoit, Philippe Guillaume, Jean-Charles Cerottini, et al.European Journal of Immunology|December 3, 2014
Differential expression of the immunosuppressive enzyme IL4I1 in human induced Aiolos+, but not natural Helios+, FOXP3+ Treg cellsClara-Maria Scarlata, Clotilde Celse, Pascale Pignon, et al.Haematologica|August 10, 2012
MHC class II/ESO tetramer-based generation of in vitro primed anti-tumor T-helper lines for adoptive cell therapy of cancerCaroline Poli, Caroline Raffin, Danijel Dojcinovic, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 27, 2013
Human memory Helios- FOXP3+ regulatory T cells (Tregs) encompass induced Tregs that express Aiolos and respond to IL-1β by downregulating their suppressor functionsCaroline Raffin, Pascale Pignon, Clotilde Celse, et al.The Journal of Clinical Investigation|July 12, 2005
A peripheral circulating compartment of natural naive CD4 TregsDanila Valmori, Andrea Merlo, Naira E Souleimanian, et al.Clinical Immunology (Orlando, Fla.)|August 17, 2005
Quantitative and qualitative assessment of circulating NY-ESO-1 specific CD4+ T cells in cancer-free individualsDanila Valmori, Naira E Souleimanian, Charles S Hesdorffer, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 8, 2003
Decreased binding of peptides-MHC class I (pMHC) multimeric complexes to CD8 affects their binding avidity for the TCR but does not significantly impact on pMHC/TCR dissociation rateValérie Dutoit, Philippe Guillaume, Maha Ayyoub, et al.Proceedings of the National Academy of Sciences of the United States of America|April 7, 2010
Monitoring of NY-ESO-1 specific CD4+ T cells using molecularly defined MHC class II/His-tag-peptide tetramersMaha Ayyoub, Danijel Dojcinovic, Pascale Pignon, et al.Pageof 8